Comparing Immune-Humanized Platforms: Which One is Best for My Application?
Immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate immune function. This webinar explores differences in immune engraftment based on the cells implanted and the host used to support those populations. Topics covered include:
- Differences in human immune cell reconstitution following engraftment with HSC or PBMC
- How genetic modification of the host influences hematopoietic humanization
- Introduction of two new host platforms that improve human innate immune development